SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-013332
Filing Date
2022-05-13
Accepted
2022-05-13 16:16:35
Documents
53
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 920728
2 ex31-1.htm EX-31.1 11838
3 ex31-2.htm EX-31.2 11844
4 ex32.htm EX-32 9114
  Complete submission text file 0001493152-22-013332.txt   4795439

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE envb-20220331.xsd EX-101.SCH 38323
6 XBRL CALCULATION FILE envb-20220331_cal.xml EX-101.CAL 42498
7 XBRL DEFINITION FILE envb-20220331_def.xml EX-101.DEF 169981
8 XBRL LABEL FILE envb-20220331_lab.xml EX-101.LAB 342221
9 XBRL PRESENTATION FILE envb-20220331_pre.xml EX-101.PRE 255345
47 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 795616
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

IRS No.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38286 | Film No.: 22922929
SIC: 2834 Pharmaceutical Preparations